SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-025722
Filing Date
2022-07-07
Accepted
2022-07-07 17:00:37
Documents
1
Period of Report
2022-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4590
  Complete submission text file 0000899243-22-025722.txt   7096
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 CAMBRIDGE PARKWAY 8TH FLOOR CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY 8TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Pioneering Fund VII, L.P. (Reporting) CIK: 0001805916 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 221072212

Mailing Address 55 CAMBRIDGE PARKWAY 8TH FLOOR CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY 8TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Pioneering Fund VII General Partner LLC (Reporting) CIK: 0001805917 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 221072213